MedTrace Logo

Early Screen and Treatment for Gestational Diabetes

NCT02377531 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1020

Last updated 2021-06-02

No results posted yet for this study

Summary

In the current study we aim to determine if early glucose screening and treatment among women at high risk for GDM improves perinatal outcome and decreases gestational weight gain. Half of the participant will be assigned to an early glucose screen group (12-18 weeks) and treatment if necessary and the other half to a standard 24-28 weeks glucose screen.

Conditions

  • Gestational Diabetes

Interventions

OTHER

Early glucose screen group

Main intervention is randomization: half of the participants will be randomized to undergo a 50 gram oral glucose load with a 1 hour serum glucose measurement as a screen for Gestational Diabetes mellitus at 12 to 18 weeks of pregnancy instead of standard 24 to 28 weeks of pregnancy

OTHER

Standard glucose screen group

Main intervention is randomization: half of the participants will be randomized to undergo a 50 gram oral glucose load with a 1 hour serum glucose measurement as a screen for Gestational Diabetes mellitus at 24 to 28 weeks of pregnancy

Sponsors & Collaborators

  • University of South Florida

    lead OTHER

Principal Investigators

  • Alejandro Rodriguez, MD · University of South Florida

  • Judette Louis, MD, MPH · University of South Florida

  • Linda Odibo · University of South Florida

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2021-07-31
Completion
2021-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02377531 on ClinicalTrials.gov